Visiomed Group SA
Klea Holding SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions, including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. The company … Read more
Visiomed Group SA - Asset Resilience Ratio
Visiomed Group SA (VMDGF) has an Asset Resilience Ratio of 79.75% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2021)
This chart shows how Visiomed Group SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Visiomed Group SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $27.44 Million | 79.75% |
| Total Liquid Assets | $27.44 Million | 79.75% |
Asset Resilience Insights
- Very High Liquidity: Visiomed Group SA maintains exceptional liquid asset reserves at 79.75% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Visiomed Group SA Industry Peers by Asset Resilience Ratio
Compare Visiomed Group SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Visiomed Group SA (2019–2021)
The table below shows the annual Asset Resilience Ratio data for Visiomed Group SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.02% | $7.00K | $44.07 Million | -0.51pp |
| 2020-12-31 | 0.52% | $31.00K | $5.91 Million | -2.29pp |
| 2019-12-31 | 2.82% | $415.00K | $14.73 Million | -- |